{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:08:38Z","timestamp":1779023318818,"version":"3.51.4"},"reference-count":16,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":228,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.csbj.2021.08.026","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T02:22:08Z","timestamp":1629339728000},"page":"4751-4758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Regulatory network analysis defines unique drug mechanisms of action and facilitates patient-drug matching in alopecia areata clinical trials"],"prefix":"10.34133","volume":"19","author":[{"given":"James C.","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Dermatology, Columbia University Medical Center, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenpeng","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Columbia University Medical Center, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Christiano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Columbia University Medical Center, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89776","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Kennedy Crispin M.","year":"2016","unstructured":"Kennedy Crispin M. et al: Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight 2016; 1. e89776.","journal-title":"JCI Insight"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/exd.13060","article-title":"Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers","volume":"25","author":"Jabbari A.","year":"2016","unstructured":"Jabbari A. et al: Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers. Exp. Dermatol. 2016; 25: 642.","journal-title":"Exp. Dermatol."},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89790","article-title":"Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata","volume":"1","author":"Mackay-Wiggan J.","year":"2016","unstructured":"Mackay-Wiggan J. et al: Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. JCI Insight 2016; 1. e89790.","journal-title":"JCI Insight"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.03.036"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0190-9622(99)70195-7","article-title":"Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation","volume":"40","author":"Olsen E.","year":"1999","unstructured":"Olsen E., Hordinsky M., McDonald-Hull S., Price V., Roberts J., Shapiro J. et al: Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 1999; 40: 242.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/imammb\/dqx009"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11538-020-00707-0","article-title":"Toward predicting the spatio-temporal dynamics of alopecia areata lesions using partial differential equation analysis","volume":"82","author":"Dobreva A.","year":"2020","unstructured":"Dobreva A., Paus R. and Cogan N.G.: Toward predicting the spatio-temporal dynamics of alopecia areata lesions using partial differential equation analysis. Bull Math Biol 2020; 82: 34.","journal-title":"Bull Math Biol"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(18)32987-8","article-title":"JAK inhibitors and alopecia areata","volume":"393","author":"Gilhar A.","year":"2019","unstructured":"Gilhar A., Keren A. and Paus R.: JAK inhibitors and alopecia areata. Lancet 2019; 393: 318.","journal-title":"Lancet"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cels.2015.11.001","article-title":"Master regulators of infiltrate recruitment in autoimmune disease identified through network-based molecular deconvolution","volume":"1","author":"Chen J.","year":"2015","unstructured":"Chen J., Cerise J., Jabbari A., Clynes R. and Christiano A.: Master regulators of infiltrate recruitment in autoimmune disease identified through network-based molecular deconvolution. Cell Syst 2015; 1: 326.","journal-title":"Cell Syst"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-7-S1-S7","article-title":"ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context","volume":"7","author":"Margolin A.A.","year":"2006","unstructured":"Margolin A.A., Nemenman I., Basso K., Wiggins C., Stolovitzky G., Favera R.D. et al: ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinf 2006; 7.","journal-title":"BMC Bioinf"},{"key":"e_1_3_4_12_2","article-title":"Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata","volume":"6","author":"Dai Z.","year":"2021","unstructured":"Dai Z., Chen J.C., Chang Y. and Christiano A.M.: Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata. JCI Insight 2021; 6.","journal-title":"JCI Insight"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.02.019"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2010.31"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/msb.2008.2","article-title":"A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas","volume":"4","author":"Mani K.M.","year":"2008","unstructured":"Mani K.M. et al: A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Mol Syst Biol 2008; 4: 169.","journal-title":"Mol Syst Biol"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.056"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-0956-5"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021003573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037021003573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2021.08.026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:50:16Z","timestamp":1779022216000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2021.08.026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":16,"alternative-id":["10.1016\/j.csbj.2021.08.026"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2021.08.026","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory network analysis defines unique drug mechanisms of action and facilitates patient-drug matching in alopecia areata clinical trials","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2021.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}